leukemia, acute lymphocytic (all)

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,

Recruiting
  • Leukemia, Acute Lymphocytic (ALL)
  • +2 more
  • Chimeric antigen receptor T cells
  • peptide specific dendritic cell
  • Guangzhou, Guangdong, China
    Zhujiang Hospital, Southern Medical University
Aug 1, 2021

Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,

Completed
  • Leukemia, Acute Lymphocytic (ALL)
  • +7 more
  • CliniMACS
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 3, 2020

Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML) Trial run by the NCI

Completed
  • Leukemia, Acute Myelogenous (AML)
  • +4 more
  • WT1 Peptide-Pulsed Dendritic Cells
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2017

Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,

Completed
  • Leukemia, Acute Lymphocytic (ALL)
  • +6 more
  • Miltenyi Biotec CliniMACS
  • +2 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 28, 2009